MCC
CTKB icon

Money Concepts Capital’s Cytek Biosciences CTKB Stock Holding History

Money Concepts Capital’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$5.11K – 972
2022
Q4 		$5.11K Buy
+500
New +$6.72K ﹤0.01% 2337

Other funds holding CTKB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Money Concepts Capital's CTKB Position: Q1 2023 in Review

Money Concepts Capital sold out of Cytek Biosciences (CTKB) in Q1 2023, closing a stake of 500 shares — an estimated $5.11K sold.

Money Concepts Capital first reported a position in CTKB in Q4 2022 and held it in 1 quarter. The position peaked at $5.11K in Q4 2022. 102 funds tracked by Wall St. Rank hold CTKB as of Q1 2023.

  • Money Concepts Capital reported no remaining Cytek Biosciences position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 500 Cytek Biosciences shares in Q1 2023, an estimated $5.11K.
  • Money Concepts Capital first reported a position in Cytek Biosciences in Q4 2022 and held it in 1 quarter.
  • Money Concepts Capital's Cytek Biosciences position peaked at $5.11K in Q4 2022.
  • 102 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.